Supernus Pharmaceuticals Inc (SUPN)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 81,666 | -5,269 | 46,124 | 86,029 | 173,698 |
| Total assets | US$ in thousands | 1,368,070 | 1,277,670 | 1,702,510 | 1,689,150 | 1,504,100 |
| Operating ROA | 5.97% | -0.41% | 2.71% | 5.09% | 11.55% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $81,666K ÷ $1,368,070K
= 5.97%
Supernus Pharmaceuticals Inc's operating return on assets (operating ROA) has shown a gradual decline from 11.55% as of December 31, 2020, to 5.09% as of December 31, 2021, and further dropping to 2.71% as of December 31, 2022. However, there was a notable negative trend observed with a negative operating ROA of -0.41% as of December 31, 2023. Subsequently, there was a slight improvement with the operating ROA increasing to 5.97% as of December 31, 2024. This fluctuation in operating ROA may indicate changes in the company's operational efficiency and effectiveness in generating profits from its assets over the specified period. Further analysis of the company's operating performance and asset management practices would provide valuable insights into the factors influencing these trends.
Peer comparison
Dec 31, 2024